Literature DB >> 6457235

Cloning and expression of the Bacillus subtilis phage SPP1 in E. coli. I. Construction and characterization of lambda/SPP1 hybrids.

E P Amann, J N Reeve, G Morelli, B Behrens, T A Trautner.   

Abstract

We have constructed lambda/SPP1 hybrid phages by in vitro ligation of EcoRI fragments of the Bacillus subtilis phage SPP1 DNA to a lambdoid bacteriophage vector. EcoRI digestion of SPP1 generated 15 DNA fragments of which 13 could be cloned. The SPP1 DNA of such hybrids was stably maintained and replicated in Escherichia coli, as indicated by marker rescue experiments in B. subtilis. EcoRI fragment 1 of SPP1 could not be cloned although subfragments of fragment 1 resulting from spontaneous deletions which occurred during the cloning regime were consistently obtained. A region within EcoRI fragment 1 responsible for its incompatibility with replication in E. coli was defined by these experiments.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6457235     DOI: 10.1007/bf00269673

Source DB:  PubMed          Journal:  Mol Gen Genet        ISSN: 0026-8925


  29 in total

1.  The genome of Bacillus subtilis phage SPP1: the arrangement of restriction endonuclease generated fragments.

Authors:  S W Ratcliff; J Luh; A T Ganesan; B Behrens; R Thompson; M A Montenegro; G Morelli; T A Trautner
Journal:  Mol Gen Genet       Date:  1979-01-10

2.  DNA of Bacillus subtilis bacteriophage SPP1: physical mapping and localization of the origin of replication.

Authors:  P K McIntosh; R Dunker; C Mulder; N C Brown
Journal:  J Virol       Date:  1978-12       Impact factor: 5.103

3.  The transformation of Escherichia coli with deoxyribonucleic acid isolated from bacteriophage lambda-dg.

Authors:  A D KAISER; D S HOGNESS
Journal:  J Mol Biol       Date:  1960-12       Impact factor: 5.469

4.  Transformation of Salmonella typhimurium by plasmid deoxyribonucleic acid.

Authors:  E M Lederberg; S N Cohen
Journal:  J Bacteriol       Date:  1974-09       Impact factor: 3.490

5.  Physical properties of the DNA of bacteriophage SP50.

Authors:  N Biswal; A K Kleinschmidt; H C Spatz; T A Trautner
Journal:  Mol Gen Genet       Date:  1967

Review 6.  Transfection in B. subtilis.

Authors:  T A Trautner; H C Spatz
Journal:  Curr Top Microbiol Immunol       Date:  1973       Impact factor: 4.291

7.  Genetic and transfection studies with B, subtilis phage SP 50. I. Phage mutants with restricted growth on B. subtilis strain 168.

Authors:  E Rottländer; T A Trautner
Journal:  Mol Gen Genet       Date:  1970

8.  Induction of mutations in B. subtilis phage SPP1 by growth on host cells carrying a mutator DNA polymerase III.

Authors:  M A Montenegro; H Esche; T A Trautner
Journal:  Mol Gen Genet       Date:  1976-12-08

9.  Nonchromosomal antibiotic resistance in bacteria: genetic transformation of Escherichia coli by R-factor DNA.

Authors:  S N Cohen; A C Chang; L Hsu
Journal:  Proc Natl Acad Sci U S A       Date:  1972-08       Impact factor: 11.205

10.  Transcription after bacteriophage SPP1 infection in Bacillus subtilis.

Authors:  G Milanesi; G Cassani
Journal:  J Virol       Date:  1972-08       Impact factor: 5.103

View more
  4 in total

1.  Genomic organization of the related Bacillus subtilis bacteriophages SPP1, 41c, rho 15, and SF6.

Authors:  M A Santos; J Almeida; H de Lencastre; G Morelli; M Kamke; T A Trautner
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

2.  Genome of Bacillus subtilis Bacteriophage SPP1: Structure and Nucleotide Sequence of pac, the Origin of DNA Packaging.

Authors:  I Deichelbohrer; W Messer; T A Trautner
Journal:  J Virol       Date:  1982-04       Impact factor: 5.103

3.  Cloning and expression of Bacillus subtilis phage SPP1 in E. coli. II. Expression of lambda/SPP1 hybrid phages in E. coli minicells.

Authors:  E P Amann; J N Reeve
Journal:  Mol Gen Genet       Date:  1981

4.  Engineered Bacteriophage Therapeutics: Rationale, Challenges and Future.

Authors:  Małgorzata Łobocka; Krystyna Dąbrowska; Andrzej Górski
Journal:  BioDrugs       Date:  2021-04-21       Impact factor: 5.807

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.